Geordan Garrett Pursglove First Wave Bio Pharma, Inc. (FWBI) insider trading activity

Geordan Garrett Pursglove is Director of First Wave BioPharma, Inc.. Currently has a direct ownership of 40,000 shares of FWBI, which is worth approximately $39,600. The most recent transaction as insider was on Jan 01, 2026, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40K

n/a 3M change

n/a 12M change

Total Value Held $39,600

Geordan Garrett Pursglove Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 01 2026	BUY Grant, award, or other acquisition	-	40,000 Added 50.0%	40,000 Common Stock

Also insider at

LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC. Healthcare

CEO and Chairman of the Board

GGP